ASolution Pharmaceuticals

Mumbai, India Founded: 2010 • Age: 16 yrs
Provides API manufacturing, pharmaceutical development, and clinical supply services in India.

About ASolution Pharmaceuticals

ASolution Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 2010 by Nandkumar Chodankar. It provides API manufacturing, pharmaceutical development, and clinical supply services in India. It operates on a B2B model. ASolution Pharmaceuticals has raised $4.55 million across 1 funding round. The company has 119 employees. Its chief executive, as recorded, is Nandkumar Chodankar. Its Indian entity Asolution Pharmaceuticals Private Limited reported revenue of β‚Ή32.73 Cr. ASolution Pharmaceuticals offers products and services including API Manufacturing, Formulation Development, Synthetic Chemistry, and Analytical Development. Its focus areas include Healthcare and Life Sciences, Pharmaceuticals, Formulation Development and Clinical Supply. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.

Company details

ASolution Pharmaceuticals, founded in 2010, is an Indian company led by experienced professionals. It specializes in cost-efficient CGMP services for APIs, finished formulations, and specialty molecules, covering synthetic chemistry, analytical development, and formulation. Based in Mumbai and Ambernath, it serves from early development to commercial manufacturing, holding certifications like US FDA and WHO GMP for global clients.

  • Headquarters Mumbai, India
  • Employees 119
  • Founders Nandkumar Chodankar
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website asolution.in
  • Legal Name Asolution Pharmaceuticals Private Limited
  • Date of Incorporation 07 May, 2010
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹32.73 Cr

    FY 2024 · +11% YoY

  • Net Loss
    -₹8.58 Cr

    FY 2024 · -26% margin

  • EBITDA
    -₹15.4 Lakh

    FY 2024 · 0% margin

  • Total Equity Funding
    $4.55M (USD)

    in 1 rounds

  • Latest Funding Round
    $4.55M (USD), Series A

    Feb 2011

  • Employee Count
    119

Products & Services of ASolution Pharmaceuticals

ASolution Pharmaceuticals offers a comprehensive portfolio of products and services, including API Manufacturing, Formulation Development, Synthetic Chemistry, and Analytical Development.

API Manufacturing
Manufacturing Service

Develops and manufactures active pharmaceutical ingredients under CGMP standards.

Formulation Development
Drug Development

Provides services for creating finished pharmaceutical formulations.

Synthetic Chemistry
Chemical Services

Offers chemical synthesis for pharmaceutical applications.

Analytical Development
Testing Services

Conducts analytical testing for drug development processes.

Funding Insights of ASolution Pharmaceuticals

ASolution Pharmaceuticals has successfully raised a total of $4.55M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.55 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.55M
  • Total Rounds 1
  • Last Round Series A β€” $4.55M
  • First Round $4.55M

    (Feb 2011)

All 1 funding rounds of ASolution Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2011$4.55MSeries A––
–

Board of directors of Asolution Pharmaceuticals Private Limited (ASolution Pharmaceuticals)

Asolution Pharmaceuticals Private Limited is the primary company behind ASolution Pharmaceuticals. The board of Asolution Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Nandkumar Kashinath Chodankar, appointed in 2010.

DirectorDesignationAppointedTenureEntity
Nandkumar Kashinath Chodankar
DIN 02736718
Director07 May 201016 yrs 6 moAsolution Pharmaceuticals Private Limited
Laxmi Nandkumar Chodankar
DIN 02868705
Director07 May 201016 yrs 6 moAsolution Pharmaceuticals Private Limited

People of ASolution Pharmaceuticals

1 people are tracked at ASolution Pharmaceuticals (1 in leadership); the tracked headcount is 119.

NameRoleGroup
Founder, CEOLeadership
Premium access

Complete people profiles for ASolution Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of ASolution Pharmaceuticals

Figures of Asolution Pharmaceuticals Private Limited, the primary company behind ASolution Pharmaceuticals, for FY 2024. Revenue was ₹32.73 Cr (+11% year on year). Net loss was -₹8.58 Cr (-26% margin). EBITDA was -₹15.4 Lakh (0% margin). Revenue has grown at a compounded annual rate of +20% over three years and +13% over five years.

  • ₹32.73 CrRevenue · FY 2024 · +11% YoY
  • -₹8.58 CrNet loss · -26% margin
  • -₹15.4 LakhEBITDA · 0% margin
  • ₹4.89 CrPaid-up capital
  • 119Employees (provident fund records)
  • +20%Revenue CAGR, 3 years
  • +13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Asolution Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for ASolution Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of ASolution Pharmaceuticals

2 dated milestones of ASolution Pharmaceuticals across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded ASolution Pharmaceuticals is founded.
  2. Funding First funding round of $4.5M.

Competitors of ASolution Pharmaceuticals

ASolution Pharmaceuticals has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indoco.com1947Mumbai, India6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
concordbiotech.com2000Ahmedabad, India1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
bdrpharma.com2003Mumbai, India$88.16M1,864
APIs and finished products are developed and manufactured.
Premium access

Detailed competitors of ASolution Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ASolution Pharmaceuticals

ASolution Pharmaceuticals was founded in 2010 and raised its 1st funding round 1 year after it was founded.

ASolution Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Nandkumar Chodankar is the CEO of ASolution Pharmaceuticals, as recorded in our data. They have also founded this company.

ASolution Pharmaceuticals is a funded company, having raised a total of $4.55M across 1 funding round to date. The company's 1st funding round was a Series A of $4.55M, raised on Feb 2011.

ASolution Pharmaceuticals has 119 employees.

The primary company behind ASolution Pharmaceuticals, Asolution Pharmaceuticals Private Limited, reported revenue of β‚Ή32.73 Cr for FY 2024, up 11% year on year.

ASolution Pharmaceuticals, founded in 2010, is an Indian company led by experienced professionals. It specializes in cost-efficient CGMP services for APIs, finished formulations, and specialty molecules, covering synthetic chemistry, analytical development, and formulation. Based in Mumbai and Ambernath, it serves from early development to commercial manufacturing, holding certifications like US FDA and WHO GMP for global clients.

ASolution Pharmaceuticals's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.

ASolution Pharmaceuticals offers API Manufacturing, Formulation Development, Synthetic Chemistry, and Analytical Development.

ASolution Pharmaceuticals operates through Asolution Pharmaceuticals Private Limited.

The legal entities of ASolution Pharmaceuticals currently have 2 directors, including Nandkumar Kashinath Chodankar, Laxmi Nandkumar Chodankar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available